Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00279097 · ClinicalTrials.gov registry record · NA
Safety Study to Evaluate Intracranial Pressure During High Frequency Chest Wall Oscillation
A NA study, sponsored by Hill-Rom.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00279097 is a NA study that was terminated before completion, run by Hill-Rom. The registered enrollment target is 20 participants.
The verdict
NCT00279097, a NA study, was terminated before completion, sponsored by Hill-Rom.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate changes in intracranial pressure (ICP) during or immediately following high frequency chest wall oscillation (HFCWO) treatment with the Vest™ in neurosurgical subjects.
Interventions
- DEVICE High Frequency Chest Wall Oscillation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2006-01 |
| Est. Completion | 2006-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00279097
The ClinicalTrials.gov registry entry for NCT00279097 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hill-Rom, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which High Frequency Chest Wall Oscillation is the first listed.
NCT00279097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00279097 about?
NCT00279097 is a clinical study titled "Safety Study to Evaluate Intracranial Pressure During High Frequency Chest Wall Oscillation". The purpose of this study is to evaluate changes in intracranial pressure (ICP) during or immediately following high frequency chest wall oscillation (HFCWO) treatment with the Vest™ in neurosurgical subjects.
What is the current status of trial NCT00279097?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2006-01. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00279097?
The interventions under investigation include: High Frequency Chest Wall Oscillation (DEVICE).
Who is sponsoring clinical trial NCT00279097?
This trial is sponsored by Hill-Rom, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.